Zura Bio Limited
ZURA | NASDAQ
$4.50
+$0.04 (+0.90%)
At close: Sep 21, 2026, 4:00 PM ET
$4.59
+$0.09 (+2.00%)
Pre-market:
Sep 22, 2026, 9:09 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 |
|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a |
Operating Income | -75.25M | -55.19M | -62.64M | -27.16M | -1.09M |
Interest Income | 6.34M | 8M | 2.19M | 570 | 23.48K |
Pretax Income | -68.65M | -52.4M | -60.56M | -27.33M | 8.42M |
Net Income | -68.65M | -52.4M | -60.36M | -25.74M | 8.42M |
Selling & General & Admin | 33.16M | 30.79M | 18.64M | 3.47M | 1.09M |
Research & Development | 42.08M | 24.4M | 44M | 23.69M | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 75.25M | 55.19M | 62.64M | 27.16M | 1.09M |
Interest Expense | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 75.25M | 55.19M | 62.64M | 27.16M | 1.09M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 94.16M | 75.07M | 33.06M | 17.25M | 17.25M |
Shares Outstanding (Diluted) | 94.16M | 75.07M | 33.06M | 17.25M | 17.25M |
EPS (Basic) | -1.06 | -0.60 | -2.09 | -1.88 | 0.40 |
EPS (Diluted) | -1.06 | -0.60 | -2.09 | -1.88 | 0.40 |
EBITDA | -68.6M | -52.39M | -60.56M | -27.33M | 8.42M |
EBIT | -68.65M | -52.4M | -60.56M | -27.33M | 8.42M |
Depreciation & Amortization | 49K | 9K | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ZURA